GSK:NYE-GlaxoSmithKline PLC (USD)

EQUITY | Drug Manufacturers - General | New York Stock Exchange

Last Closing

USD 41.61

Change

+0.50 (+1.22)%

Market Cap

USD 92.50B

Volume

4.24M

Analyst Target

USD 48.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-29 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

+13.18 (+1.71%)

USD 733.28B
JNJ Johnson & Johnson

-3.37 (-2.18%)

USD 360.64B
MRK Merck & Company Inc

-0.20 (-0.15%)

USD 329.42B
ABBV AbbVie Inc

-1.86 (-1.12%)

USD 293.88B
NVS Novartis AG ADR

+0.27 (+0.26%)

USD 210.24B
PFE Pfizer Inc

-0.11 (-0.38%)

USD 162.29B
BMY Bristol-Myers Squibb Company

-0.67 (-1.52%)

USD 89.25B
RCDTF Recordati Industria Chimica e ..

N/A

USD 11.56B
OGN Organon & Co

-0.03 (-0.14%)

USD 5.25B

ETFs Containing GSK

HSUK:PA 11.43 % 0.00 %

N/A

N/A
HSUK:LSE 11.42 % 0.00 %

N/A

N/A
FASA:LSE 6.12 % 0.00 %

N/A

N/A
FASE:LSE 6.03 % 0.00 %

N/A

N/A
UKCHBH:SW 5.67 % 0.00 %

N/A

N/A
UKUSBH:SW 5.66 % 0.00 %

N/A

N/A
UKEUBH:SW 5.64 % 0.00 %

N/A

N/A
UKUSAH:SW 5.49 % 0.00 %

N/A

N/A
ESIH:LSE 5.26 % 0.00 %

N/A

N/A
STWX:SW 5.20 % 0.00 %

N/A

N/A
SXDPEX:SW 5.18 % 0.00 %

N/A

N/A
HEAE:LSE 5.09 % 0.00 %

N/A

N/A
HLTH:LSE 5.08 % 0.00 %

N/A

N/A
ESIH:F 5.06 % 0.00 %

N/A

N/A
ESIH:XETRA 5.06 % 0.00 %

N/A

N/A
UKSR:SW 4.97 % 0.00 %

N/A

N/A
UKSRT:SW 4.97 % 0.00 %

N/A

N/A
UKSRE:SW 4.88 % 0.00 %

N/A

N/A
PPH VanEck Pharmaceutical ETF 4.78 % 0.36 %

+0.08 (+0%)

USD 0.56B
100UKD:SW 4.65 % 0.00 %

N/A

N/A
XDNA:CA iShares Genomics Immunolo.. 4.34 % 0.00 %

N/A

CAD 4.89M
LEMV:LSE 4.27 % 0.00 %

N/A

N/A
C2MV:SW 4.00 % 0.00 %

N/A

N/A
LGUK:LSE 3.74 % 0.00 %

N/A

N/A
UC63:LSE 3.61 % 0.00 %

N/A

N/A
UC64:LSE 3.61 % 0.00 %

N/A

N/A
UKCHF:SW 3.59 % 0.00 %

N/A

N/A
UKGBPB:SW 3.59 % 0.00 %

N/A

N/A
UKUKD:SW 3.59 % 0.00 %

N/A

N/A
UKUSD:SW 3.59 % 0.00 %

N/A

N/A
FLXD:SW 3.47 % 0.00 %

N/A

N/A
XDUK:LSE 3.46 % 0.00 %

N/A

N/A
VUKE:SW 3.46 % 0.00 %

N/A

N/A
UB03:LSE 3.45 % 0.00 %

N/A

N/A
UFMB:XETRA 3.44 % 0.00 %

N/A

N/A
ISF:SW 3.42 % 0.00 %

N/A

N/A
SXR3:XETRA 3.40 % 0.00 %

N/A

N/A
CSUK:SW 3.40 % 0.00 %

N/A

N/A
FLXD:LSE 3.40 % 0.00 %

N/A

N/A
FRXD:LSE 3.40 % 0.00 %

N/A

N/A
FLGB Franklin FTSE United King.. 3.33 % 0.09 %

-0.10 (0%)

USD 0.75B
HUKX:LSE 3.33 % 0.00 %

N/A

N/A
F100:AU 3.32 % 0.00 %

N/A

N/A
VUKE:LSE 3.31 % 0.00 %

N/A

N/A
VUKG:LSE 3.31 % 0.00 %

N/A

N/A
FPXE First Trust IPOX Europe E.. 3.29 % 0.00 %

+0.06 (+0%)

USD 5.04M
100GBA:SW 3.29 % 0.00 %

N/A

N/A
IPXE:LSE 3.27 % 0.00 %

N/A

N/A
CSUKX:SW 3.26 % 0.00 %

N/A

N/A
HUKX:SW 3.25 % 0.00 %

N/A

N/A
FPXE:LSE 3.24 % 0.00 %

N/A

N/A
JUKC:LSE 3.13 % 0.00 %

N/A

N/A
JUKE:LSE 3.13 % 0.00 %

N/A

N/A
PID:CA Purpose International Div.. 2.92 % 0.68 %

N/A

CAD 0.07B
FTAD:SW 2.87 % 0.00 %

N/A

N/A
FTAL:SW 2.87 % 0.00 %

N/A

N/A
FTAL:LSE 2.77 % 0.00 %

N/A

N/A
FTAD:LSE 2.77 % 0.00 %

N/A

N/A
IQD:CA CI WisdomTree Internation.. 2.43 % 0.65 %

N/A

CAD 0.19B
HSEP:LSE 2.40 % 0.00 %

N/A

N/A
HSEU:LSE 2.40 % 0.00 %

N/A

N/A
HSED:LSE 2.40 % 0.00 %

N/A

N/A
HSEU:PA 2.39 % 0.00 %

N/A

N/A
HSEU:SW 2.39 % 0.00 %

N/A

N/A
H413:XETRA 2.34 % 0.00 %

N/A

N/A
DIVD Altrius Global Dividend E.. 2.19 % 0.00 %

-0.18 (0%)

USD 7.04M
IEDL:LSE 2.18 % 0.00 %

N/A

N/A
IEVL:LSE 2.18 % 0.00 %

N/A

N/A
IEFV:LSE 2.17 % 0.00 %

N/A

N/A
MOTI 2.16 % 0.57 %

N/A

N/A
GOAT:LSE 2.15 % 0.00 %

N/A

N/A
IEVL:SW 2.15 % 0.00 %

N/A

N/A
GOGB:LSE 2.14 % 0.00 %

N/A

N/A
VVGM:XETRA 2.09 % 0.00 %

N/A

N/A
OP4E:PA 1.94 % 0.00 %

N/A

N/A
OP4E:XETRA 1.94 % 0.00 %

N/A

N/A
FLDM:CA 1.92 % 0.44 %

N/A

N/A
ZPDX:F 1.87 % 0.00 %

N/A

N/A
DRDR:LSE 1.76 % 0.00 %

N/A

N/A
IMV:LSE 1.76 % 0.00 %

N/A

N/A
MVED:LSE 1.76 % 0.00 %

N/A

N/A
MVEU:LSE 1.76 % 0.00 %

N/A

N/A
IMVU:LSE 1.76 % 0.00 %

N/A

N/A
2B78:F 1.75 % 0.00 %

N/A

N/A
IDY 1.75 % 0.00 %

N/A

N/A
MVEU:SW 1.73 % 0.00 %

N/A

N/A
HEAL:LSE 1.72 % 0.00 %

N/A

N/A
KLDW Knowledge Leaders Develop.. 1.47 % 0.75 %

+0.17 (+0%)

USD 0.14B
QEFA SPDR® MSCI EAFE Strategi.. 1.10 % 0.30 %

-0.06 (0%)

USD 0.97B
RODM Hartford Multifactor Deve.. 1.01 % 0.31 %

N/A

USD 1.15B
MFDX PIMCO RAFI Dynamic Multi-.. 0.79 % 0.40 %

+0.04 (+0%)

USD 0.26B
JPIN JPMorgan Diversified Retu.. 0.45 % 0.40 %

N/A

USD 0.38B
ADRD 0.00 % 0.26 %

N/A

N/A
ADRU 0.00 % 0.30 %

N/A

N/A
ALFI 0.00 % 0.88 %

N/A

N/A
DBUK 0.00 % 0.45 %

N/A

N/A
DIVY Reality Shares DIVS ETF 0.00 % 0.85 %

-0.08 (0%)

USD 0.01B
DOL WisdomTree International .. 0.00 % 0.48 %

-0.05 (0%)

USD 0.53B
DOO 0.00 % 0.58 %

N/A

N/A
DTH WisdomTree International .. 0.00 % 0.58 %

-0.17 (0%)

USD 0.34B
DXPS 0.00 % 0.48 %

N/A

N/A
EFV 0.00 % 0.39 %

N/A

N/A
EPV ProShares UltraShort FTSE.. 0.00 % 0.95 %

+0.02 (+0%)

USD 0.02B
EWU iShares MSCI United Kingd.. 0.00 % 0.47 %

-0.12 (0%)

USD 2.77B
HEWU 0.00 % 0.00 %

N/A

N/A
HFXE 0.00 % 0.30 %

N/A

N/A
IDHQ Invesco S&P International.. 0.00 % 0.29 %

+0.19 (+0%)

USD 0.29B
IDV 0.00 % 0.49 %

N/A

N/A
IHDG WisdomTree International .. 0.00 % 0.58 %

+0.14 (+0%)

USD 2.57B
PICB Invesco International Cor.. 0.00 % 0.00 %

-0.09 (0%)

USD 0.13B
PXF Invesco FTSE RAFI Develop.. 0.00 % 0.00 %

-0.01 (0%)

USD 1.74B
PXF Invesco FTSE RAFI Develop.. 0.00 % 0.45 %

-0.01 (0%)

USD 1.74B
QGBR 0.00 % 0.30 %

N/A

N/A
DWMF WisdomTree International .. 0.00 % 0.38 %

+0.03 (+0%)

USD 0.04B
ZGBR 0.00 % 0.30 %

N/A

N/A
IDNA iShares Genomics Immunolo.. 0.00 % 0.00 %

+0.07 (+0%)

USD 0.14B
IQD-B:CA CI WisdomTree Internation.. 0.00 % 0.00 %

N/A

CAD 0.40B
UPV ProShares Ultra FTSE Euro.. 0.00 % 0.95 %

-0.06 (0%)

USD 4.91M
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

N/A

CAD 0.01B
CSUK:LSE 0.00 % 0.00 %

N/A

N/A
CUKX:LSE 0.00 % 0.00 %

N/A

N/A
ISF:LSE 0.00 % 0.00 %

N/A

N/A
ISFD:LSE 0.00 % 0.00 %

N/A

N/A
ISFU:LSE 0.00 % 0.00 %

N/A

N/A
PSRU:LSE 0.00 % 0.00 %

N/A

N/A
LCUK:LSE 0.00 % 0.00 %

N/A

N/A
UKMV:LSE 0.00 % 0.00 %

N/A

N/A
UKSR:LSE 0.00 % 0.00 %

N/A

N/A
XSDR:LSE 0.00 % 0.00 %

N/A

N/A
XUKX:LSE 0.00 % 0.00 %

N/A

N/A
ZWUK:LSE 0.00 % 0.00 %

N/A

N/A
SGQE:PA 0.00 % 0.00 %

N/A

N/A
STW:PA 0.00 % 0.00 %

N/A

N/A
UKX:PA 0.00 % 0.00 %

N/A

N/A
10AI:F 0.00 % 0.00 %

N/A

N/A
C068:F 0.00 % 0.00 %

N/A

N/A
CEMS:F 0.00 % 0.00 %

N/A

N/A
D5BL:F 0.00 % 0.00 %

N/A

N/A
DBXA:F 0.00 % 0.00 %

N/A

N/A
DBXX:F 0.00 % 0.00 %

N/A

N/A
DBXZ:F 0.00 % 0.00 %

N/A

N/A
DXSE:F 0.00 % 0.00 %

N/A

N/A
EEUX:F 0.00 % 0.00 %

N/A

N/A
EL42:F 0.00 % 0.00 %

N/A

N/A
EL4H:F 0.00 % 0.00 %

N/A

N/A
EUN0:F 0.00 % 0.00 %

N/A

N/A
EXV4:F 0.00 % 0.00 %

N/A

N/A
FLXD:F 0.00 % 0.00 %

N/A

N/A
H4ZB:F 0.00 % 0.00 %

N/A

N/A
H4ZE:F 0.00 % 0.00 %

N/A

N/A
IUSZ:F 0.00 % 0.00 %

N/A

N/A
LCUK:F 0.00 % 0.00 %

N/A

N/A
SPYE:F 0.00 % 0.00 %

N/A

N/A
SPYF:F 0.00 % 0.00 %

N/A

N/A
SPYH:F 0.00 % 0.00 %

N/A

N/A
SXR3:F 0.00 % 0.00 %

N/A

N/A
SXRW:F 0.00 % 0.00 %

N/A

N/A
UEF3:F 0.00 % 0.00 %

N/A

N/A
UIM3:F 0.00 % 0.00 %

N/A

N/A
VUKE:F 0.00 % 0.00 %

N/A

N/A
XDUK:F 0.00 % 0.00 %

N/A

N/A
2B78:XETRA 0.00 % 0.00 %

N/A

N/A
C068:XETRA 0.00 % 0.00 %

N/A

N/A
CEMS:XETRA 0.00 % 0.00 %

N/A

N/A
D5BL:XETRA 0.00 % 0.00 %

N/A

N/A
DBXA:XETRA 0.00 % 0.00 %

N/A

N/A
DBXX:XETRA 0.00 % 0.00 %

N/A

N/A
DBXZ:XETRA 0.00 % 0.00 %

N/A

N/A
DXSE:XETRA 0.00 % 0.00 %

N/A

N/A
EUN0:XETRA 0.00 % 0.00 %

N/A

N/A
EXV4:XETRA 0.00 % 0.00 %

N/A

N/A
H4ZB:XETRA 0.00 % 0.00 %

N/A

N/A
H4ZE:XETRA 0.00 % 0.00 %

N/A

N/A
IQQD:XETRA 0.00 % 0.00 %

N/A

N/A
IUSZ:XETRA 0.00 % 0.00 %

N/A

N/A
LCUK:XETRA 0.00 % 0.00 %

N/A

N/A
SPYE:XETRA 0.00 % 0.00 %

N/A

N/A
SPYF:XETRA 0.00 % 0.00 %

N/A

N/A
SPYH:XETRA 0.00 % 0.00 %

N/A

N/A
SXRW:XETRA 0.00 % 0.00 %

N/A

N/A
UEF3:XETRA 0.00 % 0.00 %

N/A

N/A
UIM3:XETRA 0.00 % 0.00 %

N/A

N/A
VUKE:XETRA 0.00 % 0.00 %

N/A

N/A
XDUK:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRD:XETRA 0.00 % 0.00 %

N/A

N/A
1389:TSE 0.00 % 0.00 %

N/A

N/A
1392:TSE 0.00 % 0.00 %

N/A

N/A
ZPDX:XETRA 0.00 % 0.00 %

N/A

N/A
FLEQ:LSE 0.00 % 0.00 %

N/A

N/A
FREQ:LSE 0.00 % 0.00 %

N/A

N/A
FICS First Trust International.. 0.00 % 0.00 %

-0.06 (0%)

USD 0.11B
SCHY Schwab International Divi.. 0.00 % 0.00 %

-0.14 (0%)

USD 0.79B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.28% 73% C 85% B
Dividend Return 1.10% 55% F 50% F
Total Return 13.37% 73% C 86% B+
Trailing 12 Months  
Capital Gain 14.94% 91% A- 68% D+
Dividend Return 4.02% 64% D 59% D-
Total Return 18.96% 91% A- 69% C-
Trailing 5 Years  
Capital Gain 2.97% 50% F 48% F
Dividend Return 22.73% 90% A- 78% C+
Total Return 25.70% 60% D- 52% F
Average Annual (5 Year Horizon)  
Capital Gain -1.76% 22% F 32% F
Dividend Return 2.90% 33% F 42% F
Total Return 4.66% 100% F 79% B-
Risk Return Profile  
Volatility (Standard Deviation) 15.72% 67% D+ 67% D+
Risk Adjusted Return 18.47% 33% F 42% F
Market Capitalization 92.50B 36% F 98% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Drug Manufacturers - General) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 13.87 82% 61%
Price/Book Ratio 5.05 45% 17%
Price / Cash Flow Ratio 13.47 55% 27%
Price/Free Cash Flow Ratio 10.47 64% 40%
Management Effectiveness  
Return on Equity 46.38% 90% 96%
Return on Invested Capital 25.94% 91% 92%
Return on Assets 8.30% 82% 88%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector